Skip to content

The application of combined index of consciousness (IOC) and neuromuscular monitoring in the anesthetic management of patients undergoing neoadjuvant chemotherapy before surgery.

The application of combined index of consciousness (IOC) and neuromuscular monitoring in the anesthetic management of patients undergoing neoadjuvant chemotherapy before surgery.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400091897
Enrollment
Unknown
Registered
2024-11-05
Start date
2024-11-08
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian cancer

Interventions

IOC2 Monitoring Group:IOC2 was used as a pain monitor to adjust opioid dosage during surgery
Control Group:The dosage of opioids was adjusted according to standardized anesthesia (patients vital signs such as heart rate and blood pressure)

Sponsors

Affiliated Cancer Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: 1. Age = 18 years and = 64 years. 2. Preoperative diagnosis of ovarian cancer via biopsy. 3. American Society of Aneshesiologists (ASA) II-III classification. 4. BMI 18.5-28 kg/m². 5. Preoperatively received at least 3 cycles of neoadjuvant chemotherapy with a combination of paclitaxel and carboplatin (21 days/cycle), followed by imaging assessment and Fagotti scoring 2 weeks later, indicating suitability for surgery under total intravenous anesthesia for open abdominal cytoreductive surgery of malignant ovarian tumors.

Exclusion criteria

Exclusion criteria: 1. Planned laparoscopic or robotic surgery. 2. History of long-term alcohol, opioid, or other analgesic use (= 3 months). 3. Allergies to anesthetic agents. 4. Emergency surgery. 5. History of radiotherapy or other chemotherapy regimens. 6. Patient is pregnant or breastfeeding. 7. Diagnosed with mental illness or other autonomic nervous system disorders that may affect Electroencephalogram (EEG) results. 8. Significant hepatic or renal dysfunction, or history of cardiopulmonary disease.

Design outcomes

Primary

MeasureTime frame
Mean intraoperative opioid consumption (MMEs);

Secondary

MeasureTime frame
The average amount of propofol used during the operation;Extubation time and recovery time upon admission to the PACU;The NRS scores for activity and resting state on the day of surgery (4 hours post-operation), the first day after surgery (24 hours post-operation), and the second day after surgery (48 hours post-operation);The use of rescue analgesics and antiemetics on the day of surgery (4 hours post-operation), the first day after surgery (24 hours post-operation), and the second day after surgery (48 hours post-operation);Postoperative 24-hour QoR-15 score, time to first flatus, time to first ambulation, pelvic drainage volume, postoperative hospital stay duration, and total length of hospital stay.;The highest NRS score in the PACU, the amount of morphine accumulated in the PACU;

Countries

CHINA

Contacts

Public ContactXiaolan Gu

Affiliated Cancer Hospital of Nanjing Medical University

xiaolan0652@sina.com+86 153 8088 2965

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026